Middle East Pharmaceutical Industries Company (TADAWUL:4016)

Saudi Arabia · Delayed Price · Currency is SAR

97.60

+0.40 (0.41%)

Mar 24, 2026, 2:13 PM AST

Revenue by Segment

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Private Customers		245.32M	207.97M	-	-
Private Customers Growth		17.96%	-	-	-
Public Customers		55.91M	68.58M	-	-
Public Customers Growth		-18.48%	-	-	-
Export Customers		37.22M	26.11M	-	-
Export Customers Growth		42.54%	-	-	-
Medicines		-	-	157.70M	113.51M
Medicines Growth		-	-	38.94%	-
Cosmetics		-	-	129.52M	188.15M
Cosmetics Growth		-	-	-31.16%	-
Total		338.44M	302.66M	287.22M	301.66M
Total Growth		11.82%	5.38%	-4.79%	-

Revenue by Geography

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Kingdom of Saudi Arabia		301.22M	276.55M	259.78M	279.08M
Kingdom of Saudi Arabia Growth		8.92%	6.46%	-6.91%	-
Kuwait		9.35M	-	-	-
United Arab Emirates		12.93M	-	-	-
Other Export		-	26.11M	27.44M	22.58M
Other Export Growth		-	-4.85%	21.52%	-
Other Countries		14.94M	-	-	-
Total		338.44M	302.66M	287.22M	301.66M
Total Growth		11.82%	5.38%	-4.79%	-

Source: S&P Global Market Intelligence.